Selank (11mg) research peptide vial
RUO
Popular Peptides

Selank (11mg)

Selank (TP-7)

Purity 98%+
Form Lyophilized Powder
Molecular Weight 751.89 g/mol
CAS Number See COA
Dosage: 11mg
Also known as: Selank, TP-7
Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
Research Areas
Anxiolytic Research Nootropic Effects Immunomodulation Neuroprotection
Buy at Research Vials

Overview

Selank 11mg contains the same selank heptapeptide as the 10mg product — a synthetic derivative of tuftsin with anxiolytic, nootropic, and immunomodulatory properties. The mechanism involves GABA-A receptor modulation, enkephalin-degrading enzyme inhibition, and BDNF expression enhancement. See the Selank 10mg entry for comprehensive research details. The 11mg vial provides slightly more material than the 10mg version, offering flexibility for research protocols that require marginally larger quantities per vial.

Mechanism of Action

Selank 11mg contains the same selank heptapeptide as the 10mg product — a synthetic derivative of tuftsin with anxiolytic, nootropic, and immunomodulatory properties. The mechanism involves GABA-A receptor modulation, enkephalin-degrading enzyme inhibition, and BDNF expression enhancement. See the Selank 10mg entry for comprehensive research details. The 11mg vial provides slightly more material than the 10mg version, offering flexibility for research protocols that require marginally larger quantities per vial.

Key Research Findings

  • Seredenin et al. (1998) showed selank produces anxiolytic effects comparable to benzodiazepines without sedation.
  • Kost et al. (2001) demonstrated selank inhibits enkephalin-degrading enzymes, potentially enhancing endogenous opioid activity.
  • Zozulya et al. (2008) showed selank modulates IL-6 and T-helper cell balance.

Citations & References

1

Anxiolytic action of Selank

Seredenin SB, Kozlovskii II, Blednov IuA, et al. — Bull Exp Biol Med (1998)

2

Inhibitory effect of selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity

Kost NV, Sokolov OY, Kurasova OB, et al. — Bull Exp Biol Med (2001)

Dosage in Research

Intranasal doses of 250-500 mcg/day in Russian clinical studies. Animal studies: 100-300 mcg/kg.

Dosage information is derived from published research literature and is presented for educational purposes only. This is not medical advice. All products are for laboratory research use only.

Storage & Handling

Store lyophilized (freeze-dried) powder at -20°C to 4°C in a dry environment protected from light. Unreconstituted peptide is stable for extended periods when stored properly.

Once reconstituted with bacteriostatic water or an appropriate solvent, store at 2-8°C and use within the timeframe specified on the Certificate of Analysis. Avoid repeated freeze-thaw cycles.

A Certificate of Analysis documenting purity, identity, and recommended storage conditions is included with every order.

Frequently Asked Questions

What is Selank (11mg)?
A higher-dose formulation of the tuftsin-derived peptide Selank, investigated for nootropic, anxiolytic, and immunomodulatory activity in research models.
What purity is your Selank (11mg)?
Our Selank (11mg) is manufactured at 98%+ purity, verified through third-party HPLC analysis and mass spectrometry. A Certificate of Analysis (COA) is included with every order.
How should I store Selank (11mg)?
Store lyophilized powder in a cool, dry place at 2-8°C away from direct light. Once reconstituted, refrigerate and use within the timeframe specified on the COA.
Is Selank (11mg) for human use?
No. Selank (11mg) is sold strictly for laboratory research use only. It is not intended for human consumption, veterinary use, or as a food additive. Products have not been evaluated by the FDA. Purchasers must be 21+ and confirm research use intent.
Where can I buy Selank (11mg)?
Selank (11mg) is available for purchase at researchvials.com. All orders include a COA and ship with temperature-controlled packaging.

Research Use Only

All products are intended for laboratory research and educational purposes only. Products have not been evaluated by the FDA and are not intended for human consumption, diagnosis, treatment, or prevention of any disease. Purchasers must be 21+ and confirm research use intent.